Table 1.

Type of adjuvant and aluminum content of aluminum-adjuvanted vaccines licensed for use in the United States (Information accessed on FDA website on May 24, 2018 (https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm093833.htm))

Vaccine	Tradename	Manufacturer	Adjuvant	Dose (Al3+)
Anthrax	BioThrax®	Emergent Biosolutions	AH	1.2 mg
Diphtheria and Tetanus Toxoids Adsorbed		Sanofi-Pasteur	AP	0.33 mg
DTaP	Daptacel®	Sanofi-Pasteur	AP	0.33 mg
	Infanrix®	GSK	AH	≤0.625 mg
DTaP, Hepatitis B, polio	Pediarix®	GSK	AH	≤0.85 mg
DTaP, polio	Kinrix®	GSK	AH	≤0.6 mg
	Quadracel®	Sanofi-Pasteur	AP	0.33 mg
DTaP, polio, Hib	Pentacel®	Sanofi-Pasteur	AP	0.33 mg
Hib	PedVaxHIB®	Merck	AAHS	0.225 mg
Hepatitis A	Havrix®	GSK	AH	0.5 mg (adult)
				0.25 mg (pediatric)
	VAQTA®	Merck	AAHS	0.45 mg (adult)
				0.225 mg (pediatric)
Hepatitis A and Hepatitis B	Twinrix®	GSK	AH and AP	0.45 mg
Hepatitis B	Engerix	GSK	AH	0.5 mg (adult)
				0.25 mg (pediatric)
	Recombivax HB®	Merck	AAHS	0.5 mg (adult)
				0.25 mg (pediatric)
Human papilloma virus	Cervarix®	GSK	AH	0.5 mg (plus 50 µg MPLA)
	Gardasil®	Merck	AAHS	0.225 mg
	Gardasil-9®	Merck	AAHS	0.5 mg
Meningococcus B	Bexsero®	GSK	AH	0.519 mg
	Trumenba®	Pfizer	AP	0.25 mg
Pneumococcus	Prevnar 13®	Pfizer	AP	0.125 mg
Tetanus and Diphtheria Toxoids, Adsorbed	Tenivac®	MassBiologics	AP	≤0.53 mg
		Sanofi-Pasteur	AP	0.33 mg
TdaP	Adacel®	Sanofi-Pasteur	AP	0.33 mg
	Boostrix®	GSK	AH	≤0.39 mg

DTaP diphtheria toxoid, tetanus toxoid, acellular pertussis, Hib Haemophilus influenzae B, TdaP tetanus toxoid, reduced diphtheria toxoid, acellular pertussis, AH aluminum hydroxide adjuvant, AP aluminum phosphate adjuvant, AAHS amorphous aluminum hydroxyphosphate sulfate